Cytek Biosciences, Inc. (CTKB) bonds
CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.70+0.07 (+1.24%)
Close on Nov 17, 2026Market cap $740.91MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Cytek Biosciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Cytek Biosciences's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued |
|---|---|---|
| Wuxi Loan | Floating + 0.20% | $800.00K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Bank of China Maximum Credit Agreement | $5.20M |
| Bank of Communication, China, Loan Agreement | CN¥10.00M |
| Bank of Ningbo Maximum Credit Agreement | CN¥10.00M |
| China Construction Bank Corporation, Loan Agreement | CN¥15.00M |
| Revolving Credit Facility | CN¥10.00M |
See a number that looks wrong?